SIRT1 and metabolic disease: Resveratrol, a known SIRT1 agonist, has been proven to improve mitochondrial function by stimulating SIRT1 expression and maintaining PGC-1α activity in metabolic diseases (Lagouge et al., 2006), COPD (Wang X. L. et al., 2017).